LMR Partners’s Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share CTV.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,074,838
Closed -$43.2K 1702
2024
Q3
$43.2K Buy
+1,074,838
New +$41.2K ﹤0.01% 1082

Other funds holding CTV.WS

LMR Partners's CTV.WS Position: Q1 2025 in Review

LMR Partners sold out of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) in Q1 2025, closing a stake of 1,057,495 shares — an estimated $116K sold.

LMR Partners first reported a position in CTV.WS in Q4 2021 and held it in 12 quarters. The position peaked at $2.91M in Q3 2022. 1 fund tracked by Wall St. Rank holds CTV.WS as of Q1 2025.

  • LMR Partners reported no remaining Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q1 2025 after selling out during the quarter.
  • LMR Partners sold 1,057,495 Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q1 2025, an estimated $116K.
  • LMR Partners first reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q4 2021 and held it in 12 quarters.
  • LMR Partners's Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $2.91M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q1 2025.

Based on LMR Partners's 13F filing for Q1 2025, filed 15 May 2025.